Omega Funds — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
X4 PharmaceuticalsNASDAQ: XFORApr 2016SEC filingmedium confidence
BiotechBoston, US
Mary DiBiase(Executive Officer)Christophe Arbet-Engels(Executive Officer)David Kirske(Executive Officer)John Volpone(Executive Officer)Mark Baldry(Executive Officer)Adam Craig(Executive Officer, Director)
Board seatClaudio Nessi· per SEC Form D · $50.5M raise · filed May 2017
Co-investorsPolaris Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.